BEAT - BioTelemetry cheers Needham's Buy initiation September, 11 2020 01:34 PM Heartbeam Inc. Needham initiated BioTelemtry (BEAT +6.0%) with a Buy rating, price target of $52, indicating upside of 33% from current levels.More news on: BioTelemetry, Inc., Healthcare stocks news, Stocks on the move, Read more ...